| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 2.1K | 60.2% | 12.9% |
| Total Income | 2.1K | 59.3% | 12.6% |
| Expenditure | 1.7K | 47.2% | 4.2% |
| PBT | 422.08 | 136.4% | 64.8% |
| Net Profit | 318.72 | 119.6% | 56.5% |
| OPM | 23.59% | 4.89pp | 7.01pp |
| NPM | 15.27% | 4.19pp | 4.29pp |
| EPS | 35.32 | 119.5% | 56.5% |
Sharda Cropchem FY26 PAT More Than Doubles to ₹681 Cr
13 May 2026 · 13 May, 2:58 pm
Summary
Sharda Cropchem Limited concluded a landmark financial year FY26, reporting a 22% year-on-year surge in consolidated revenue to ₹5,268 crores. This strong top-line growth was accompanied by a remarkable 124% increase in Profit After Tax (PAT), which reached ₹681 crores, and a 69% rise in EBITDA to ₹1,040 crores, leading to significantly expanded margins of 19.7%. Chairman and MD, Mr. Ramprakash Bubna, attributed the performance to strong volume momentum, an improved product mix, and accelerating contributions from an expanding registration pipeline. The company also achieved its highest-ever Return on Capital Employed of 30.4% and remains debt-free, with management expressing confidence in sustaining momentum into FY27 backed by a robust registration base and expanding market presence.
Key Highlights
- 1
Sharda Cropchem Limited reported a 22% year-on-year growth in FY26 consolidated revenue, reaching ₹5,268 crores.
- 2
Profit After Tax (PAT) for FY26 more than doubled, increasing by 124% year-on-year to ₹681 crores.
- 3
EBITDA for the financial year FY26 grew by 69% to ₹1,040 crores, with margins expanding significantly to 19.7%.
- 4
The company achieved its highest-ever Return on Capital Employed (RoCE) of 30.4% for FY26, underscoring disciplined capital allocation.
- 5
Q4 FY26 consolidated revenue stood at ₹2,065 crores, marking a 13% year-on-year increase.
- 6
The company remains debt-free, holding cash, bank, and liquid investments totaling ₹702 crores as of March 31, 2026.
- 7
Product registrations reached 3,011, with an additional 1,004 applications pending at various stages by the end of FY26.
Management Comments
Ramprakash Bubna
FY26 has been a landmark year for Sharda Cropchem. Our revenue grew 22% to Rs. 5,268 crores, driven by strong volume momentum, an improved product mix, and the accelerating contribution of our expanding registration pipeline across geographies. This strategic investment in registrations is now visibly translating into sustainable top-line growth. EBITDA grew 69% to Rs. 1,040 crores, with margins expanding meaningfully to 19.7%. Our PAT more than doubled to Rs. 681 crores — a 124% growth year-on-year — reflecting the operating leverage in our model as scale and efficiency come together. We are also proud to report our highest-ever Return on Capital Employed of 30.4% for FY26, a testament to disciplined capital allocation and the inherent strength of our asset-light business model. As we look ahead, the Company is well positioned to sustain this momentum, and we enter FY27 with confidence backed by a robust registration base, expanding market presence, and a resilient operating framework.
Informational and educational content only. Not investment advice.